학술논문
Efficacy of vedolizumab for induction of clinical response and remission in patients with moderate to severe inflammatory bowel disease who failed at least two TNF antagonists
Document Type
Article
Author
Source
In: United European Gastroenterology Journal . (United European Gastroenterology Journal, 1 April 2018, 6(3):439-445)
Subject
Language
English
ISSN
20506414
20506406
20506406